Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis

British Journal of Ophthalmology

Volumn 84, Issue 10, 2000, Pages 1130-1134

  Sugita, S ^a   Mochizuki, M ^a   Taguchi, C ^b   Takase, H ^a   Sagawa, K ^b   Sueda, J ^b   Fukushi, K ^b   Hikita, N ^b   Watanabe, T ^c   Itoh, K ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; HLA B27 ANTIGEN;

ADULT; AGE; AGED; AQUEOUS HUMOR; ARTICLE; BEHCET DISEASE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IRIDOCYCLITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; SAMPLING; SARCOIDOSIS; SERUM; SYMPATHETIC OPHTHALMIA; TOXOPLASMOSIS; UVEITIS; VIRUS INFECTION; VITREOUS BODY; VOGT KOYANAGI SYNDROME;

ADULT; AGED; ANTIGENS, CD95; AQUEOUS HUMOR; CATARACT; FAS LIGAND PROTEIN; HUMANS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; SOLUBILITY; UVEITIS; VITREOUS BODY;

EID: 0033816056     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.10.1130     Document Type: Article

References (32)

1. Immunologically privileged sites
2. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor
3. The presence of biologically significant concentrations of glucocorticoids but little or no cortisol binding globulin within aqueous humor: Relevance to immune privilege in the anterior chamber of the eye
4. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of aqueous humor
5. Identification of transforming growth factor beta as an immunosuppressive factor in aqueous humor
6. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye
7. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor
8. The Fas death factor
9. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
10. Phenotype and function of human B cells expressing CD70 (CD27 ligand)
11. CD40 and its ligand
12. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity
13. Fas-mediated cytotoxicity by freshly isolated natural killer cells
14. Expression of the Fas ligand in cells of T cell lineage
15. Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family
16. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
17. A role for CD95 ligand in preventing graft rejection
18. Fas ligandinduced apoptosis as a mechanism of immune privilege
19. Metalloproteinasemediated release of human Fas ligand
20. Expression of the functional soluble form of human Fas ligand in activated lymphocytes
21. Divergent induce of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen
22. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis
23. The Fas death factor
24. Apoptosis in the pathogenesis and treatment of disease
25. Downregulation of Fas ligand by shedding
26. Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis
27. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
28. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing
29. Fas ligand in human serum
30. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T cell leukemia virus type-1 uveitis
31. Cell biology in endogeneous uveitis
32. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule